93 related articles for article (PubMed ID: 20201397)
1. [In vitro investigation of Ingavirin efficacy against influenza B virus].
Loginova SIa; Borisevich SV; Semenova IA; Borisevich GV; Maksimov VA; Bondarev VP; Nebol'sin VE
Antibiot Khimioter; 2009; 54(7-8):13-5. PubMed ID: 20201397
[TBL] [Abstract][Full Text] [Related]
2. [In vitro activity of Ingavirin against influenza virus A (H3N2)].
Loginova SIa; Borisevich SV; Semenova IV; Maksimov VA; Bondarev VP; Nebol'sin VE
Antibiot Khimioter; 2009; 54(9-10):23-6. PubMed ID: 20415259
[TBL] [Abstract][Full Text] [Related]
3. [In vitro efficacy of ingavirin against the Mexican pandemic subtype H1N1 of influenza A virus, strains A/California/04/2009 and A/California/07/2009].
Loginova SIa; Borisevich SV; Lykov MV; Vedenina EV; Borisevich GV; Bondarev VP; Nebol'sin VE; Chuchalin AG
Antibiot Khimioter; 2009; 54(3-4):15-7. PubMed ID: 19711843
[TBL] [Abstract][Full Text] [Related]
4. [In vitro Ingavirin efficacy against adenoviral infection pathogen].
Loginova SIa; Borisevich SV; Maksimov VA; Bondarev VP; Nebol'sin VE
Antibiot Khimioter; 2009; 54(7-8):16-8. PubMed ID: 20201398
[TBL] [Abstract][Full Text] [Related]
5. [Antiviral effect of Ingavirin against seasonal influenza virus A/H1N1 in MDCK cell culture].
Galegov GA; Andronova VL; Nebol'sin VE
Antibiot Khimioter; 2009; 54(9-10):19-22. PubMed ID: 20415258
[TBL] [Abstract][Full Text] [Related]
6. [In vitro efficacy of Ingavirin against the pandemic influenza virus A(H1N1/09)v].
Shishkina LN; Nebol'sin VE; Kabanov AS; Skarnovich MO; Erdyneeva UB; Mazurkova NA; Serova OA; Stavskiĭ EA; Drozdov IG
Antibiot Khimioter; 2010; 55(3-4):12-6. PubMed ID: 20695202
[TBL] [Abstract][Full Text] [Related]
7. [Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models].
Leneva IA; Fediakina IT; Eropkin MIu; Gudova NV; Romanovskaia AA; Danilenko DM; Vinogradova SM; Lepeshkin AIu; Shestopalov AM
Vopr Virusol; 2010; 55(3):19-27. PubMed ID: 20608077
[TBL] [Abstract][Full Text] [Related]
8. [Experimental investigation of Ingavirin antiviral activity against human parainfluenza virus].
Zarubaev VV; Krivitskaia VZ; Nebol'sin VE; Kiselev OI
Antibiot Khimioter; 2010; 55(7-8):13-6. PubMed ID: 21140558
[TBL] [Abstract][Full Text] [Related]
9. [In vitro and in vivo effects of ingavirin on the ultrastructure and infectivity of influenza virus].
Zarubaev VV; Beliaevskaia SV; Sirotkin AK; Anfimov PM; Nebol'sin VE; Kiselev OI; Reĭkhart DV
Vopr Virusol; 2011; 56(5):21-5. PubMed ID: 22171473
[TBL] [Abstract][Full Text] [Related]
10. [Experimental study of Ingavirin antiviral activity against human adenovirus].
Zarubaev VV; Slita AV; Sirotkin AK; Nebol'sin VE; Kiselev OI
Antibiot Khimioter; 2010; 55(9-10):19-24. PubMed ID: 21400749
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic efficacy of Ingavirin, a new domestic formulation against influenza A virus (H3N2)].
Loginova SIa; Borisevich SV; Maksimov VA; Bondarev VP; Nebol'sin VE
Antibiot Khimioter; 2008; 53(7-8):27-30. PubMed ID: 19227120
[TBL] [Abstract][Full Text] [Related]
12. [In vitro investigation of the antiviral activity of Ingavirin against human metapneumovirus].
Isaeva EI; Nebol'sin VE; Kozulina IS; Morozova OV
Vopr Virusol; 2012; 57(1):34-8. PubMed ID: 22624471
[TBL] [Abstract][Full Text] [Related]
13. [Effect of the antiviral drug Ingaviruin on intracellular transformations and import into the nucleus of influenza A virus nucleocapsid protein].
Semenova NP; Prokudina EN; Livov DK; Nebol'sin VE
Vopr Virusol; 2010; 55(5):17-20. PubMed ID: 21260990
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of prophylactic activity of Ingavirin, a new Russian drug, against grippe A virus (H3N2)].
Loginova SIa; Borisevich SV; Maksimov VA; Bondarev VP; Nebol'sin VE
Antibiot Khimioter; 2008; 53(11-12):19-21. PubMed ID: 19441652
[TBL] [Abstract][Full Text] [Related]
15. [In vitro and in vivo efficacy of Ingavirin against strains of pandemic influenza virus A(H1N1/09)v].
Shishkina LN; Nebol'sin VE; Kabanov AS; Skarnovich MO; Mazurkova NA; Sergeev AA; Serova OA; Stavskiĭ EA; Drozdov IG
Zh Mikrobiol Epidemiol Immunobiol; 2011; (2):93-6. PubMed ID: 21598625
[TBL] [Abstract][Full Text] [Related]
16. [Antiviral activity of Ingavirin in experimental lethal influenza due to influenza virus B in albino mice].
Zarubaev VV; Garshinina AV; Kalinina NA; Shtro AA; Nebol'sin VE; Kiselev OI
Antibiot Khimioter; 2010; 55(3-4):8-11. PubMed ID: 20695201
[TBL] [Abstract][Full Text] [Related]
17. [In vivo efficacy of Ingavirin against pandemic A (H1N1/09)v influenza virus].
Shishkina LN; Nebol'sin VE; Skarnovich MO; Kabanov AS; Sergeev AA; Erdyneeva UB; Serova OA; Demina OK; Agafonov AP; Stavskiĭ EA; Drozdov IG
Antibiot Khimioter; 2010; 55(5-6):32-5. PubMed ID: 21033472
[TBL] [Abstract][Full Text] [Related]
18. [Antiviral activity of Ingavirin on an animal model for experimental disseminated adenovirus infection].
Zarubaev VV; Slita AV; Beliaevskaia SV; Nebol'sin VE; Kiselev OI; Reĭkhart DV
Vopr Virusol; 2011; 56(6):23-7. PubMed ID: 22359945
[TBL] [Abstract][Full Text] [Related]
19. [Protective activity of Ingavirin in experimental lethal influenza due to pandemic influenza virus A (H1N1)v in albino mice].
Zarubaev VV; Garshinina AV; Kalinina NA; Shtro AA; Beliaevskaia SV; Nebol'sin VE; Kiselev OI
Antibiot Khimioter; 2010; 55(5-6):24-31. PubMed ID: 21033471
[TBL] [Abstract][Full Text] [Related]
20. [Experimental study of Grippferon antiviral activity against Mexican pandemic influenza virus A/H1N1/2009 in vitro].
Loginova SIa; Borisevich SV; Shchukina VN; Borisevich GV; Bondarev VP; Shevtsov VA
Antibiot Khimioter; 2011; 56(5-6):7-10. PubMed ID: 22145225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
